|
|
|
Volumn 3, Issue 8, 2007, Pages 600-602
|
|
Emerging agents for the medical therapy of hepatocellular carcinoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
CETUXIMAB;
CISPLATIN;
DOXORUBICIN;
ERLOTINIB;
GEFITINIB;
PLACEBO;
SORAFENIB;
SUNITINIB;
CANCER MORTALITY;
CANCER SURVIVAL;
CHEMOEMBOLIZATION;
CLINICAL FEATURE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DRUG EFFICACY;
DRUG FATALITY;
DRUG INHIBITION;
DRUG MECHANISM;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL HEMORRHAGE;
HUMAN;
LIVER CELL CARCINOMA;
LIVER FAILURE;
LIVER FUNCTION;
MONOTHERAPY;
NONHUMAN;
NOTE;
RADIOFREQUENCY ABLATION;
TREATMENT RESPONSE;
VASCULAR DISEASE;
|
|
EID: 34648846218
PISSN: 15547914
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
